While the promise of early detection is appealing, critics and some medical professionals urge caution regarding the rapid expansion of private, for-profit scanning clinics. A primary concern is the risk of over-diagnosis and the potential for 'incidentalomas'—findings that appear abnormal on a scan but are clinically insignificant. Such results can lead to unnecessary anxiety, follow-up testing, and invasive procedures that may do more harm than good for otherwise healthy individuals.
There are also significant questions regarding equity and the role of these services in the broader healthcare landscape. With scans often priced as out-of-pocket expenses, these clinics risk creating a two-tiered system where advanced preventive care is accessible only to the wealthy. Critics argue that this diverts resources and attention away from primary care and public health initiatives that serve the general population, potentially exacerbating existing health disparities rather than solving them.
Furthermore, the lack of formal integration with national health systems or primary care providers in some regions raises concerns about the continuity of care. If a scan identifies a potential issue, the burden often falls on the patient to navigate the traditional medical system to confirm the diagnosis and seek treatment. Without standardized protocols or clear evidence that these specific scans improve long-term survival rates, some experts warn that the industry is driven more by consumer anxiety and marketing than by proven clinical benefit. As Neko Health enters the U.S. market, the debate over whether these services are a medical necessity or a luxury wellness product will likely intensify.